Pediatric Type III Supracondylar Humeral Fracture

NCT ID: NCT04780308

Last Updated: 2021-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-01

Study Completion Date

2015-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to compare pin configuration effects on early secondary displacement in the surgical treatment of pediatric supracondylar humeral fractures (SCHF).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consisted of 100 (68M, 32F) children who underwent surgery between 2010 and 2013 for Gartland Type 3 (SCHF). The patients divided into five groups according to the top in configurations (crossed 1 lateral 1 medial, crossed 2 lateral 1 medial, crossed 1 lateral 2 medial, 2 lateral divergent, and 3 lateral divergent). The average age at the time of injury was 7.34 (between 2 and 14 years). Bauman angle (BA), Humerocapital angle (HCA), Anterior humeral line (AHL), flexion range, extension range, and Carrying angle (CA) were compared at preoperative, postoperative 1st-day, postoperative last control, and non-operated side. The mean follow-up time 24,96±11,06 with a range of 12-54 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supracondylar Humerus Fracture Pediatric Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 medial 1 lateral K-wire

Pediatric Gartland Type 3 supracondylar humeral fractures fixed by 1 medial 1 lateral K-wire

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Intervention Type PROCEDURE

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

1 medial 2 lateral K-wire

Pediatric Gartland Type 3 supracondylar humeral fractures fixed by 1 medial 2 lateral K-wire

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Intervention Type PROCEDURE

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

2 medial 1 lateral K-wire

Pediatric Gartland Type 3 supracondylar humeral fractures fixed by 2 medial 1 lateral K-wire

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Intervention Type PROCEDURE

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

2 lateral K-wire

Pediatric Gartland Type 3 supracondylar humeral fractures fixed by 2 lateral K-wire

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Intervention Type PROCEDURE

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

3 lateral K-wire

Pediatric Gartland Type 3 supracondylar humeral fractures fixed by 3 lateral K-wire

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Intervention Type PROCEDURE

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric Gartland Type 3 supracondylar humeral fracture
* Patients operated between 2010-2013
* Patients under 16 years old

Exclusion Criteria

* Pathological fractures
* Conservative treated supracondylar fractures
* Less than the 1-year follow-up
* Patients with incomplete postoperative follow-up
* Patients older than 16 years
* Pediatric Gartland Type 1 and 2 supracondylar humeral fracture
Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alkan Bayrak

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014/18/05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.